DK302181A - Bloede steroider med anti-inflammatorisk aktivitet og fremgangsmaade til deres fremstilling - Google Patents

Bloede steroider med anti-inflammatorisk aktivitet og fremgangsmaade til deres fremstilling

Info

Publication number
DK302181A
DK302181A DK302181A DK302181A DK302181A DK 302181 A DK302181 A DK 302181A DK 302181 A DK302181 A DK 302181A DK 302181 A DK302181 A DK 302181A DK 302181 A DK302181 A DK 302181A
Authority
DK
Denmark
Prior art keywords
steroids
blood
procedure
preparation
inflammatory activity
Prior art date
Application number
DK302181A
Other languages
English (en)
Other versions
DK165837B (da
DK165837C (da
Inventor
N S Bodor
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DK302181A publication Critical patent/DK302181A/da
Publication of DK165837B publication Critical patent/DK165837B/da
Application granted granted Critical
Publication of DK165837C publication Critical patent/DK165837C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK302181A 1980-07-10 1981-07-08 Analogifremgangsmaade til fremstilling af lokalt anti-inflammatorisk aktive 17alfa-carbonat-androst-4-en-3-on-17beta-carboxylsyreestere, der in vivo nedbrydes til ikke toksiske metabolitter DK165837C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16845380A 1980-07-10 1980-07-10
US16845380 1980-07-10
US26578581A 1981-05-21 1981-05-21
US26578581 1981-05-21

Publications (3)

Publication Number Publication Date
DK302181A true DK302181A (da) 1982-01-11
DK165837B DK165837B (da) 1993-01-25
DK165837C DK165837C (da) 1993-06-21

Family

ID=26864131

Family Applications (1)

Application Number Title Priority Date Filing Date
DK302181A DK165837C (da) 1980-07-10 1981-07-08 Analogifremgangsmaade til fremstilling af lokalt anti-inflammatorisk aktive 17alfa-carbonat-androst-4-en-3-on-17beta-carboxylsyreestere, der in vivo nedbrydes til ikke toksiske metabolitter

Country Status (17)

Country Link
KR (2) KR860000266B1 (da)
AT (1) AT379816B (da)
AU (1) AU540898B2 (da)
CA (1) CA1174667A (da)
CH (1) CH648856A5 (da)
DE (1) DE3126732C2 (da)
DK (1) DK165837C (da)
ES (2) ES8300785A1 (da)
FI (1) FI71748C (da)
FR (1) FR2486529A1 (da)
GB (1) GB2079755B (da)
IT (1) IT1205446B (da)
NL (1) NL192343C (da)
NO (1) NO163285C (da)
PH (1) PH25874A (da)
PT (1) PT73348B (da)
SE (1) SE449106B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2137206B (en) * 1980-02-15 1985-04-03 Glaxo Group Ltd Androstane 17-carbothioc acid derivatives
JPS6041607A (ja) * 1983-08-12 1985-03-05 Otsuka Pharmaceut Co Ltd 軟膏基剤
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
EP0334853B1 (en) * 1987-10-13 1993-06-09 BODOR, Nicholas S. Soft steroids having anti-inflammatory activity
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
AU8439998A (en) * 1997-06-30 1999-01-25 Glaxo Group Limited Compounds
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
PT1305329E (pt) 2000-08-05 2007-12-24 Glaxo Group Ltd Éster s-fluorometílico do ácido 6.alfa.,9.alfa.-difluoro- 17.alfa.-(2-furanilcarboxil)oxi-11.beta.-hidroxi-16.alfa.-metil- 3-oxo-androsta-1,4-dieno-17-carbotióico como um agente antiinflamatório
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
MY137522A (en) 2001-04-30 2009-02-27 Glaxo Group Ltd Novel anti-inflammatory androstane derivatives.
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
GB0316290D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
EP1841780B1 (en) 2005-01-10 2011-07-27 Glaxo Group Limited Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
AR059216A1 (es) * 2006-01-27 2008-03-19 Sun Pharmaceutical Ind Ltd 11b-hidroxiandrosta-4-eno-3-onas
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
CN101942001B (zh) * 2010-08-24 2013-02-06 山东省医药工业研究所 一种氯替泼诺的提纯方法
CN103183714A (zh) * 2011-12-29 2013-07-03 山东方明药业集团股份有限公司 一种氯替泼诺的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384372A (en) * 1971-01-20 1975-02-19 Glaxo Lab Ltd Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
IT1114534B (it) * 1978-02-08 1986-01-27 Glaxo Group Ltd Steroide anti-infiammatorio della serie dell'androstano composizioni che lo contengono e procedimento per produrlo
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung

Also Published As

Publication number Publication date
GB2079755A (en) 1982-01-27
NO163285B (no) 1990-01-22
NO812344L (no) 1982-01-11
DK165837B (da) 1993-01-25
ES514633A0 (es) 1983-06-16
ES8306767A1 (es) 1983-06-16
NL192343B (nl) 1997-02-03
DK165837C (da) 1993-06-21
SE8104132L (sv) 1982-01-11
KR830006327A (ko) 1983-09-24
KR850002759A (ko) 1985-05-15
NO163285C (no) 1990-05-02
CA1174667A (en) 1984-09-18
IT8105186A0 (it) 1981-07-09
DE3126732A1 (de) 1982-03-25
GB2079755B (en) 1985-01-30
ES504340A0 (es) 1982-12-01
ES8300785A1 (es) 1982-12-01
KR860000266B1 (ko) 1986-03-22
AT379816B (de) 1986-03-10
PT73348B (en) 1982-09-23
PT73348A (en) 1981-08-01
FI812175L (fi) 1982-01-11
DE3126732C2 (de) 1987-04-30
FR2486529A1 (fr) 1982-01-15
ATA307081A (de) 1985-07-15
FR2486529B1 (da) 1985-01-04
CH648856A5 (de) 1985-04-15
KR860000452B1 (ko) 1986-04-26
PH25874A (en) 1991-12-02
AU540898B2 (en) 1984-12-06
NL8103315A (nl) 1982-02-01
NL192343C (nl) 1997-06-04
IT1205446B (it) 1989-03-23
AU7259181A (en) 1982-01-14
FI71748B (fi) 1986-10-31
SE449106B (sv) 1987-04-06
FI71748C (fi) 1987-02-09

Similar Documents

Publication Publication Date Title
DK302181A (da) Bloede steroider med anti-inflammatorisk aktivitet og fremgangsmaade til deres fremstilling
NO814112L (no) 1-sulfo-2-oksoazetidinderivater og fremgangsmaate for deres fremstilling
DK338379A (da) Pyrazinderivater og fremgangsmaade til deres fremstilling
DK70385A (da) Bakteriepraeparat og fremgangsmaade til fremstilling deraf
DK372878A (da) Thiadiazolylcephalosporinanaloge og fremgangsmaade til fremstilling deraf
DK446982A (da) Cyanosteroider og fremgangsmaade til deres fremstilling
DK180878A (da) Fremgangsmaade til fremstilling af imidazoaziner og imidazodiaziner
DK48482A (da) Azopigmentpraeparater,fremgangsmaade til deres fremstilling og deres anvendelse
DK401882A (da) Cyclopentadienderivater og fremgangsmaader til deres fremstilling
DK251281A (da) N6-adenosiner og fremgangsmaader til deres fremstilling
DK111678A (da) Enzym-marumer og fremgangsmaade til deres fremstilling
DK308878A (da) Aminoglyosidderivater og fremgangsmaader til deres fremstilling
DK151610C (da) Fremgangsmaade til fremstilling af human-immunoglobulinpraeparater med formindsket komplementaktivitet og god antistofaktivitet
DK165336C (da) Koncentrerede stofbloedgoerende midler og fremgangsmaader til deres fremstilling
DK323378A (da) Imidazo-isoquinolin-dioner og fremgangsmaade til deres fremstilling
DK24280A (da) Spiro-quinolylhydantoiner fremgangsmaade til deres fremstilling og deres anvendelse
DK416278A (da) 2-oxazolidon-derivater og fremgangsmaade til deres fremstilling
DK21579A (da) 5-phenethyl-2-oxazolidon-derivater og fremgangsmaade til deres fremstilling
NO791520L (no) Substituerte antitumorantracycliner og fremgangsmaate for deres fremstilling
NO824312L (no) 4-cyano-2-azetidinoner og fremgangsmaate for deres fremstilling
DK118879A (da) 2-hydroxymethyl-pyrazin-derivater og fremgangsmaade til deres fremstilling
NO851687L (no) Kryssbundne karboksyl-polyelektrolytter og fremgangsmaate for deres fremstilling
DK332782A (da) 2-cyanosteroider og fremgangsmaade til deres fremstilling
DK363578A (da) Benzensulfonamidderivater og fremgangsmaade til deres fremstilling
DK258179A (da) L-cysteinderivater og fremgangsmaade til deres fremstilling

Legal Events

Date Code Title Description
PUP Patent expired